Mitral Subvalvular Aneurysm in a Patient with Chagas Disease and Recurrent Episodes of Ventricular Tachycardia

Subvalvular left ventricular aneurysm is a rare disease of obscure origin suggesting unique causes such as congenital, traumatic, and inflammatory or infectious diseases. Its mortality is closely related to heart failure, mitral insufficiency, thromboembolic phenomena, and cardiac arrhythmias. Although association with coronary artery disease is not described, the compression of epicardial vessels by the aneurysm may lead to ischemic manifestations. We report here a case of mitral subvalvular left ventricular aneurysm of probable chagasic origin, in a patient with normal left ventricular function evolving with repeated episodes of monomorphic ventricular tachycardia, despite noninducible electrophysiological testing and the use of optimal medical treatment, including amiodarone. The indication for implantable cardioverter-defibrillator in patients with Chagas cardiomyopathy and segmental wall motion abnormalities but without global systolic dysfunction remains unclear in literature, even in the presence of complex ventricular arrhythmias. A brief review of the literature on morphological features, diagnosis, prognosis, and treatment will be also discussed.

[1]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[2]  Mauro M. Teixeira,et al.  Diagnosis and management of Chagas disease and cardiomyopathy , 2012, Nature Reviews Cardiology.

[3]  P. Chiale,et al.  Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  J. Marin-Neto,et al.  I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy , 2011 .

[5]  Â. D. de Paola,et al.  Images and Case Reports in Arrhythmia and Electrophysiology Ablation of Ventricular Tachycardia in Chronic Chagasic Cardiomyopathy With Giant Basal Aneurysm Carto Sound, CT, and MRI Merge , 2011 .

[6]  C. Morillo,et al.  Chagas disease: an overview of clinical and epidemiological aspects. , 2013, Journal of the American College of Cardiology.

[7]  P. Friedman,et al.  Clinical Usefulness of Electrophysiologic Testing in Patients with Ventricular Tachycardia and Chronic Chagasic Cardiomyopathy Treated with Amiodarone or Sotalol , 2003, Journal of cardiovascular electrophysiology.

[8]  R. Isturiz,et al.  Chagas Disease , 2021, Neglected Tropical Diseases.

[9]  M. Scanavacca Epicardial Ablation for Ventricular Tachycardia in Chronic Chagas Heart Disease , 2014, Arquivos brasileiros de cardiologia.

[10]  F. Van de Werf,et al.  Ventricular tachycardia as a complication of annular subvalvular ventricular aneurysm in a Caucasian woman. , 1987, European heart journal.

[11]  A. Sivaraman,et al.  Subvalvular left ventricular aneurysms. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[12]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[13]  F. Tarasoutchi,et al.  Diretriz Brasileira de Valvopatias - SBC 2011/ I Diretriz Interamericana de Valvopatias - SIAC 2011 , 2011 .

[14]  F. Lombardi,et al.  Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  J. Skoularigis,et al.  Submitral aneurysm. , 1998, Circulation.

[16]  J. Marin-Neto,et al.  CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial. , 2013, American heart journal.